RBC Capital analyst Luca Issi maintained a Hold rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $15.00. The company’s shares closed yesterday at $15.89. Issi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
